| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.0047 | 1 |